相关实验视频

Updated: Mar 14, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

由动脉样硬化引起的关键四肢缺血症中受损的脂质稳定性和线粒体功能障碍 obliterans

Shengyuan Mao¹, Hanjun Wang¹

¹Department of Vascular Surgery, Zhejiang Hospital, Hangzhou, Zhejiang, China.

Archives of physiology and biochemistry

|March 13, 2026

概括

关键四肢缺血症 (CLI) 破坏了脂质代谢和线粒体功能. 新的血液标记物,包括胺和脂,显示出早期CLI检测和治疗的前景.

科学领域:

生物化学生物化学
分子生物学分子生物学
血管医学血管医学

背景情况:

关键四肢缺血症 (CLI) 是一种严重的外周动脉疾病,其特征是血液流量减少.
CLI破坏脂质代谢和线粒体功能,导致肌肉缩,修复功能受损,并增加肢体损失的风险.
目前对CLI的诊断主要依赖于成像和 perfusion,经常忽视关键的代谢变化.

研究的目的:

通过使用一种新的框架来调查CLI中的脂质变化.
为早期CLI检测和治疗确定潜在的非侵入性生物标志物.
探索脂质变化,线粒体功能障碍和CLI进展之间的关系.

主要方法:

开发和应用LIPID-CLI框架,使用高分辨率质谱.
在患有CLI的患者中,分析脂质资料,重点是胺和脂.
从侵入性组织活检转向分析反映组织脂质组成的血液标记物.

主要成果:

在CLI中,LIPID-CLI方法确定了与线粒体应激相关的胺和脂的显著变化.
特定的脂质标记物,包括胺,脂比率,乙卡尼丁和氧化脂 (OxPLs),显示出可量化的变化.
观察到胺度降低,正常化为总脂质含量,表明脂质稳定和线粒体功能障碍受损.

结论:

改变的脂质样本,特别是胺和脂,表明CLI中的脂质-线粒体功能障碍.
这些脂质变化可能成为早期诊断和有效治疗CLI的新型非侵入性生物标志物.
LIPID-CLI框架为了解和管理CLI中的代谢障碍提供了一个有希望的方法.

关键词:

利皮多米克 (Lipidomics) 是一种消化剂.动脉样硬化消灭消灭消灭生物标志物生物标志物关键四肢缺血是因为缺血.质谱测量质谱测量质谱测量质量测量质谱测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量质量测量线粒体功能障碍线粒体功能障碍

更多相关视频

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

相关概念视频

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...